EUVIMEDEUVIMED entdecken
Crossref

Targeted immunomodulation with CD44-targeting nanovaccine enhances antitumor immunity in melanoma through TLR7/8 and TLR3 agonists

Shameer Pillarisetti, Padmanaban Sathiyamoorthy, Tae-Young Jung, Saji Uthaman, In-Kyu Park

Biomaterials Science · 2026

DOI: 10.1039/d6bm01033d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Shameer Pillarisetti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Chonnam National University Medical School, 264 Seoyang-ro, Hwasun, Jeollanam-do 58128, Republic of Korea. pik96@j…. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Toll-Like Receptor 3, Toll-Like Receptor 8, Hyaluronan Receptors. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Research Foundation of Korea, Chonnam National University Hwasun Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schematic illustration of a CD44-targeting nanovaccine utilizing dual TLR7/8 and TLR3 agonists to drive targeted immunomodulation and overcome immune evasion in melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Toll-Like Receptor 3Toll-Like Receptor 8Hyaluronan ReceptorsMelanomaMelanoma, ExperimentalImmunomodulationCancer VaccinesAnimalsNanovaccinesMiceToll-Like Receptor AgonistsImidazolesHyaluronic AcidMice, Inbred C57BLOvalbuminPoly I-CTumor MicroenvironmentFemaleCell Line, TumorNanoparticlesMembrane Glycoproteins

Substanzen

NanovaccinesToll-Like Receptor 7Toll-Like Receptor 3Toll-Like Receptor 8Hyaluronan ReceptorsToll-Like Receptor AgonistsImidazolesresiquimodHyaluronic AcidOvalbumin

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Chonnam National University Medical School, 264 Seoyang-ro, Hwasun, Jeollanam-do 58128, Republic of Korea. pik96@jnu.ac.kr.
  • Department of Pharmacy, University of Chieti - Pescara "G. d'Annunzio", Via dei Vestini 31, 66100, Chieti, Italy.
  • Department of Neurosurgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, 322 Seoyang-ro, Hwasun, Jeollanam-do 58128, Korea.
  • Department of Polymer Science and Engineering, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Republic of Korea.
  • NanoLife Innovations Laboratory, Smart Materials and Devices Division, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India. sajiuthaman@gmail.com.
  • DRCure Inc, Hwasun, 58128, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Chonnam National University Hwasun Hospital

Zitieren

APA

Pillarisetti, S., Sathiyamoorthy, P., Jung, T. Y., Uthaman, S., & Park, I. K. (2026). Targeted immunomodulation with CD44-targeting nanovaccine enhances antitumor immunity in melanoma through TLR7/8 and TLR3 agonists. Biomaterials Science. https://doi.org/10.1039/d6bm01033d

Vancouver

Pillarisetti S, Sathiyamoorthy P, Jung TY, Uthaman S, Park IK. Targeted immunomodulation with CD44-targeting nanovaccine enhances antitumor immunity in melanoma through TLR7/8 and TLR3 agonists. Biomaterials Science. 2026. doi:10.1039/d6bm01033d

BibTeX
@article{Pillarisetti2026,
  author = {Pillarisetti, Shameer and Sathiyamoorthy, Padmanaban and Jung, Tae-Young and Uthaman, Saji and Park, In-Kyu},
  title = {Targeted immunomodulation with CD44-targeting nanovaccine enhances antitumor immunity in melanoma through TLR7/8 and TLR3 agonists},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d6bm01033d}
}
Kostenlos starten →